Voloridge Investment Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,010
Closed -$420K 1340
2024
Q3
$420K Sell
40,010
-38,426
-49% -$468K ﹤0.01% 1098
2024
Q2
$918K Sell
78,436
-157,526
-67% -$2.45M ﹤0.01% 1063
2024
Q1
$4.97M Buy
235,962
+198,242
+526% +$3.53M 0.02% 663
2023
Q4
$677K Buy
+37,720
New +$664K ﹤0.01% 995
2022
Q1
Sell
-13,372
Closed -$437K 1657
2021
Q4
$437K Sell
13,372
-75,032
-85% -$2.55M ﹤0.01% 1423
2021
Q3
$3.71M Buy
+88,404
New +$3.18M 0.02% 806
2021
Q1
Sell
-12,224
Closed -$554K 1617
2020
Q4
$554K Buy
+12,224
New +$427K ﹤0.01% 1105
2020
Q3
Sell
-44,692
Closed -$1.65M 1462
2020
Q2
$1.65M Buy
44,692
+37,433
+516% +$1.4M 0.02% 683
2020
Q1
$235K Buy
+7,259
New +$302K 0.01% 923
2019
Q1
Sell
-8,893
Closed -$373K 1041
2018
Q4
$373K Sell
8,893
-32,449
-78% -$1.9M 0.02% 357
2018
Q3
$3.12M Buy
+41,342
New +$2.98M 0.07% 178

Other funds holding RGNX

Voloridge Investment Management's RGNX Position: Q4 2024 in Review

Voloridge Investment Management sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 40,010 shares — an estimated $420K sold.

Voloridge Investment Management first reported a position in RGNX in Q3 2018 and held it in 11 quarters. The position peaked at $4.97M in Q1 2024. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Voloridge Investment Management reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 40,010 Regenxbio shares in Q4 2024, an estimated $420K.
  • Voloridge Investment Management first reported a position in Regenxbio in Q3 2018 and held it in 11 quarters.
  • Voloridge Investment Management's Regenxbio position peaked at $4.97M in Q1 2024.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.